Literature DB >> 20599922

Mutational analysis of residues important for ligand interaction with the human P2Y(12) receptor.

Yingying Mao1, Lili Zhang, Jianguo Jin, Barrie Ashby, Satya P Kunapuli.   

Abstract

The P2Y(12) receptor, a Gi protein-coupled receptor, plays a central role in platelet activation. In this study, we did a mutational analysis of residues possibly involved in the ligand interactions with the human P2Y(12) receptor. Mutant receptors were stably expressed in CHO-K1 cells with an HA-tag at the N-terminus. Expression of wild-type and mutant receptors was confirmed by detecting the HA-tag on the cell membrane. Residues in transmembrane helical domains (TMs) 3, 5, 6, and 7, which are homologous to residues important for P2Y(1) receptor activation and ligand recognition, were replaced by site-directed mutagenesis. ADP-induced inhibition of forskolin-stimulated cAMP levels in the presence or absence of antagonist AR-C69931MX were investigated for each of the mutant receptors. F104S and S288P significantly increased agonist-induced receptor function without affecting the antagonism by AR-C69931MX. Arg256 in TM6 and Arg 265 in extracellular loop 3 (EL3) are more important for antagonist recognition than effect on agonist-mediated receptor function. Compared to wild-type P2Y(12) receptor, mutations in Arg 256 or/and Arg 265 significantly increased the sensitivity to antagonist AR-C69931MX. Our study shows that the cytosolic side of TM3 and the exofacial side of TM5 are critical for P2Y(12) receptor function, which is different from P2Y(1). Arg 256 in TM6 and Arg265 in EL3 appear to play a role in antagonist recognition rather than effects on agonist-induced receptor function. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20599922      PMCID: PMC2948851          DOI: 10.1016/j.ejphar.2010.06.023

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  28 in total

1.  The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity.

Authors:  R F Storey; H M Sanderson; A E White; J A May; K E Cameron; S Heptinstall
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

2.  Identification of the platelet ADP receptor targeted by antithrombotic drugs.

Authors:  G Hollopeter; H M Jantzen; D Vincent; G Li; L England; V Ramakrishnan; R B Yang; P Nurden; A Nurden; D Julius; P B Conley
Journal:  Nature       Date:  2001-01-11       Impact factor: 49.962

3.  Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y(1) receptor.

Authors:  J Takasaki; M Kamohara; T Saito; M Matsumoto; S Matsumoto; T Ohishi; T Soga; H Matsushime; K Furuichi
Journal:  Mol Pharmacol       Date:  2001-09       Impact factor: 4.436

Review 4.  Amplification mechanisms in platelet activation and arterial thrombosis.

Authors:  F F De Clerck; P A Janssen
Journal:  J Hypertens Suppl       Date:  1990-12

5.  Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling.

Authors:  Stefano Costanzi; Liaman Mamedova; Zhan-Guo Gao; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2004-10-21       Impact factor: 7.446

6.  Thromboxane A2 causes feedback amplification involving extensive thromboxane A2 formation on close contact of human platelets in media with a low concentration of ionized calcium.

Authors:  M A Packham; R L Kinlough-Rathbone; J F Mustard
Journal:  Blood       Date:  1987-09       Impact factor: 22.113

7.  Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding.

Authors:  Marco Cattaneo; Maddalena L Zighetti; Rossana Lombardi; Constantino Martinez; Anna Lecchi; Pamela B Conley; Jerry Ware; Zaverio M Ruggeri
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

8.  Identification of the active metabolite of ticlopidine from rat in vitro metabolites.

Authors:  Kenji Yoneda; Ryou Iwamura; Hiroko Kishi; Yoichi Mizukami; Kimiko Mogami; Sei Kobayashi
Journal:  Br J Pharmacol       Date:  2004-05-17       Impact factor: 8.739

9.  Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270.

Authors:  Zhongren Ding; Soochong Kim; Robert T Dorsam; Jianguo Jin; Satya P Kunapuli
Journal:  Blood       Date:  2003-01-30       Impact factor: 22.113

10.  Akt activation in platelets depends on Gi signaling pathways.

Authors:  Soochong Kim; Jianguo Jin; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2003-11-17       Impact factor: 5.157

View more
  9 in total

Review 1.  G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions.

Authors:  Kenneth A Jacobson; Ramachandran Balasubramanian; Francesca Deflorian; Zhan-Guo Gao
Journal:  Purinergic Signal       Date:  2012-02-29       Impact factor: 3.765

Review 2.  Nucleotides Acting at P2Y Receptors: Connecting Structure and Function.

Authors:  Kenneth A Jacobson; Silvia Paoletta; Vsevolod Katritch; Beili Wu; Zhan-Guo Gao; Qiang Zhao; Raymond C Stevens; Evgeny Kiselev
Journal:  Mol Pharmacol       Date:  2015-04-02       Impact factor: 4.436

3.  Platelet P2Y₁₂ receptors are involved in the haemostatic effect of notoginsenoside Ft1, a saponin isolated from Panax notoginseng.

Authors:  B Gao; L Huang; H Liu; H Wu; E Zhang; L Yang; X Wu; Z Wang
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

4.  Structure of the human P2Y12 receptor in complex with an antithrombotic drug.

Authors:  Kaihua Zhang; Jin Zhang; Zhan-Guo Gao; Dandan Zhang; Lan Zhu; Gye Won Han; Steven M Moss; Silvia Paoletta; Evgeny Kiselev; Weizhen Lu; Gustavo Fenalti; Wenru Zhang; Christa E Müller; Huaiyu Yang; Hualiang Jiang; Vadim Cherezov; Vsevolod Katritch; Kenneth A Jacobson; Raymond C Stevens; Beili Wu; Qiang Zhao
Journal:  Nature       Date:  2014-03-23       Impact factor: 49.962

5.  Pharmacochemistry of the platelet purinergic receptors.

Authors:  Kenneth A Jacobson; Francesca Deflorian; Shilpi Mishra; Stefano Costanzi
Journal:  Purinergic Signal       Date:  2011-02-18       Impact factor: 3.765

6.  Molecular Structure of P2Y Receptors: Mutagenesis, Modeling, and Chemical Probes.

Authors:  Kenneth A Jacobson; M P Suresh Jayasekara; Stefano Costanzi
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2012-09-12

Review 7.  Blood cells: an historical account of the roles of purinergic signalling.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2015-08-11       Impact factor: 3.765

Review 8.  Adenosine-associated delivery systems.

Authors:  Mehdi Kazemzadeh-Narbat; Nasim Annabi; Ali Tamayol; Rahmi Oklu; Amyl Ghanem; Ali Khademhosseini
Journal:  J Drug Target       Date:  2015       Impact factor: 5.121

Review 9.  Rare platelet GPCR variants: what can we learn?

Authors:  S P Nisar; M L Jones; M R Cunningham; A D Mumford; S J Mundell
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.